Гендевит

Multivitamins

Treatment option: Pregnancy, Milk Ejection

Medically reviewed

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Гендевит

What is Gendevit?

Property	Description
Active Ingredient	Multivitamins (Polyvitamins)
Dosage Form	Dragee
Pharmacological Class	Vitamins and vitamin-like agents in combinations (ATC A11BA)
General Purpose	Prevention of hypovitaminosis (vitamin deficiency)
Origin	Synthetic/Semi-synthetic Combination

Gendevit is defined as a combined polyvitamin agent, a type of medicinal product containing a specific fixed mixture of multiple essential vitamins. It belongs to the pharmacological group known as Vitamins and vitamin-like agents in combinations, a classification recognized within global drug categorization systems. The medicine is prepared for oral ingestion in the specific dosage form of a dragee (a small, coated tablet).

Composition and Role of Essential Vitamins

The therapeutic action of Gendevit is derived from its key active ingredient: a balanced polyvitamin complex that includes both fat-soluble vitamins (such as Retinol (A) and Ergocalciferol (D2)) and water-soluble vitamins (such as Ascorbic acid (C) and the B-group vitamins (B1, B2, B12)). The general purpose of this combination is the prophylaxis of hypovitaminosis, providing the body with an additional source of vitamins to prevent deficiencies caused by inadequate diet or increased bodily demand.

The inclusion of multiple essential micronutrients is critical, as vitamins perform key roles in cellular function, acting as coenzymes in major metabolic pathways. For instance, B-complex vitamins, which are components of Gendevit, perform essential roles in nerve function and energy metabolism. This focus on supplementation helps maintain the body's normal physiological and metabolic processes.

What side effects are possible with Гендевит?

Possible Side Effects and Safety Information

The safety profile for this polyvitamin agent, derived from regulatory guidance for multivitamin preparations, classifies potential adverse reactions based on the body systems affected and their expected frequency. Most documented adverse reactions are generally mild and confined to the Gastrointestinal Disorders and Skin and Subcutaneous Tissue Disorders system-organ classes.

Commonly reported, non-serious reactions may include gastrointestinal upset (such as nausea, diarrhea, or abdominal discomfort) and skin manifestations (such as rash or pruritus). For certain components like Niacin (Vitamin B3), transient facial flushing is also a recognized effect documented in official safety literature.

The most significant regulatory concern is the potential for serious toxicity (hypervitaminosis), particularly from the fat-soluble vitamins, Vitamin A and Vitamin D2, when intake exceeds the established Tolerable Upper Intake Level (UL). Serious reactions associated with chronic high-dose exposure include liver impairment or intracranial hypertension from Vitamin A toxicity, and hypercalcaemia from excessive Vitamin D intake.

Population-specific safety considerations are documented for individuals with renal impairment, who may be at a higher risk of Vitamin A accumulation due to decreased elimination. The safety documents also note that neurological effects, such as sensory neuropathies associated with Vitamin B6, are typically linked to long-term exposure to cumulative high doses, rather than standard use. Additionally, the presence of folic acid may mask the hematological signs of megaloblastic anemia while allowing neurological damage to progress, a high-level safety constraint noted in labeling.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information emphasizes that overdose with a polyvitamin agent like Gendevit is primarily associated with the accumulation of fat-soluble components (Vitamin A and Vitamin D2), which can lead to hypervitaminosis.

Documented Overdose Manifestations

Symptoms officially documented in regulatory sources for high-dose ingestion include non-specific signs and those specific to hypervitaminosis:

General: Nausea, vomiting, diarrhea, headache, dizziness, and skin rash.
Specific: Bone pain, weakness, skin desquamation, blurred vision, and peripheral neuropathy (tingling or numbness) due to chronic high-dose B-vitamin intake.

Severe Outcomes and Emergency Actions

Overdose may lead to severe complications, particularly from the resulting hypercalcemia (due to Vitamin D toxicity) or chronic Vitamin A toxicity.

Severe Outcome	Required Action
Cardiovascular effects (e.g., cardiac arrhythmias) or CNS changes (e.g., confusion, coma), liver impairment, or intracranial hypertension	Seek immediate medical help and contact a Poison Control Center right away.

Urgent medical attention is required if an overdose is suspected, especially if symptoms include repeated vomiting, severe abdominal pain, or changes in thinking/mental status.

Treatment is supportive, focusing on discontinuing the supplement, and may involve clinical measures like activated charcoal, IV fluids, and specific hospital monitoring such as ECG (Electrocardiogram), as no specific antidote is described in official labeling.

Therapeutic Uses of Гендевит

Main Uses and Supportive Benefits

Gendevit is a multivitamin and multimineral formulation designed to address symptoms related to systemic imbalance by providing essential micronutrients. Multivitamin/mineral (MVM) supplements may be part of symptomatic management to help individuals work toward recommended daily intakes of vitamins and minerals.

MVMs are relevant when supportive symptom management is appropriate for several scenarios, including: individuals who are on low-calorie diets, have a poor appetite, or avoid specific food groups. This category of supplement plays a role in managing needs in conditions presenting with systemic or localized discomfort that may arise from nutritional gaps. These supplements may assist with maintaining functional stability and contribute to improved comfort in situations where the body requires additional management of discomfort due to temporary physiological imbalance.

Supportive relief is considered relevant during phases when symptoms that interfere with daily functioning become more noticeable. The supplement contributes to improved comfort during periods of heightened symptoms by addressing potential nutritional shortfalls.

“This category of supplement assists with maintaining functional stability.”

Quick Fact: Assists with managing symptoms related to physical discomfort

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Гендевит

The following rules reflect the official population eligibility and non-eligibility requirements as stated in governmental regulatory documents.

Eligibility Scope

Classification	Status and Conditions
Populations for whom use is allowed	Adults for standard prophylaxis.
Populations for whom use is contraindicated	Patients with Hypervitaminosis A or D, Severe Renal Insufficiency, Hypersensitivity to any component, Diabetes Mellitus, or Sugar Metabolism Disorders (e.g., fructose intolerance).
Conditional Use (Caution Required)	Patients with Severe Hepatic Impairment or active Peptic Ulcer Disease (gastric or duodenal ulcer).

Life Stage and Age-Related Rules

Eligibility Status	Applicable Population
Pregnancy and Lactation	Use is permitted under professional monitoring or caution (listed as a possible application).
Pediatric Population	Standard use is not explicitly established in the primary regulatory instructions.

Connection to the Overall Eligibility Profile

The regulatory profile defines eligibility primarily through absolute exclusions tied to two main factors: the risk of component accumulation (Hypervitaminosis, Severe Renal Disease) and risks related to excipient composition (Diabetes, Sugar Disorders). Use is otherwise standard for adults and conditional for groups with chronic ulcers, severe liver impairment, or women who are pregnant or lactating.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile for Gendevit, a polyvitamin agent, centers on the additive risk of excessive fat-soluble vitamin exposure and the altered absorption of certain co-administered medicinal products.

Documented Interaction Patterns

Interacting Substance/Class	Official Regulatory Statement
Other Vitamin A or D Supplements	Co-administration is restricted due to the additive pharmacodynamic risk of accumulating excessive amounts, potentially leading to hypervitaminosis.
Mineral Oil / Bile Acid Sequestrants	These substances reduce the absorption of Gendevit’s fat-soluble vitamins (A and D2); administration must be separated to prevent a significant reduction in vitamin exposure.
Anticonvulsants (e.g., Phenytoin)	These drugs increase the catabolism (breakdown) of Vitamin D2, resulting in lower effective circulating levels of the vitamin.
Ascorbic Acid (Vitamin C)	The Vitamin C component enhances the gastrointestinal absorption of non-heme iron from co-administered iron preparations.
Thiazide Diuretics	When co-administered with Vitamin D2, there is an increased risk of developing hypercalcemia due to effects on calcium homeostasis.
Tetracycline Antibiotics	Regulatory documents advise a separation of administration to prevent reduced antibiotic efficacy due to potential interference with absorption.
Chronic Alcohol Consumption	Impairs the body’s ability to absorb and store Vitamin B1 (Thiamine) and Vitamin A.

These interactions are formally defined in regulatory monographs, establishing timing rules and co-administration restrictions to manage exposure levels.

Mechanism of Action

How Гендевит Works

Гендевит (Gendevit) operates through the established physiological functions of its constituent vitamins, including Retinol (Vitamin A), Thiamine (B1), Riboflavin (B2), Pyridoxine (B6), Ascorbic Acid (C), and Tocopherol (E). Its action is exerted across distinct metabolic and cellular domains.

Modulation of Enzyme-Mediated Signaling

B vitamins such as Thiamine, Riboflavin, and Pyridoxine act as obligatory coenzymes for numerous metabolic reactions. They are essential components in enzyme systems that regulate the transfer of chemical groups within amino acid and carbohydrate metabolism, contributing to the overall metabolic flux within key energy-producing pathways.

Engagement of Antioxidant Defense Systems

Vitamin C and Vitamin E engage the cellular antioxidant defense mechanisms. These molecules influence the redox state of cellular components, protecting cell membranes and vital macromolecules from degradation by reactive oxygen species (ROS) and thereby modulating membrane structure maintenance.

Signaling for Tissue and Barrier Maintenance

Vitamin A influences systems where specific signaling patterns govern cell renewal and differentiation. It engages pathways that modulate epithelial cell proliferation and differentiation signaling, which impacts the structural integrity of the skin, mucous membranes, and visual function.

Dosage and Administration Information

The administration of Gendevit is governed by a defined, cyclical protocol. The preparation is designated for oral administration in the form of a dragee.

Instruction	Official Guideline
Route of administration	Oral (taken by mouth).
Dosing schedule (Adult Prophylaxis)	One (1) to two (2) dragees.
Frequency Pattern	Once daily.
Timing in relation to meals	Administered after meals.
Course Duration	20 to 30 days.

The standard regimen specifies a once-daily intake. A critical instruction for proper use is that the dragee must be ingested after meals, which supports the effective absorption of certain vitamin components.

The use of Gendevit follows a structured cycle, with the course typically lasting 20 to 30 days. This short-term administration is followed by a necessary break of one to three months before a subsequent course may begin, defining the long-term use pattern. For specific populations, such as during the second half of pregnancy and throughout lactation, the prescribed dose is fixed at one (1) dragee daily.

A key procedural constraint requires that the medicine not be taken concurrently with other polyvitamin preparations to prevent unintended excessive intake. This establishes a clear boundary for safe, procedural administration.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Гендевит

This overview summarizes the research base for polyvitamin agents, such as Гендевит, detailing the structure and type of evidence available without offering clinical interpretations or individual predictions.

Evidence for Prophylaxis and Correction of Micronutrient Gaps (Hypovitaminosis)

Research has explored the use of polyvitamin supplements in the context of nutritional shortfalls, which are often caused by poor dietary intake or increased bodily demand. These studies examined how taking a supplement affects the concentrations of specific nutrients, monitoring changes in serum or plasma levels towards reference ranges. Studies reported measurements where supplementation was observed in relation to a higher percentage of participants achieving biomarker levels within the target range. However, the evidence is limited regarding the full effect of the polyvitamin combination itself, as many rigorous trials often focus on individual nutrients.

Evidence for Supportive Management of Cognitive Function in Older Adults

The role of polyvitamins was evaluated in large-scale Randomized Controlled Trials (RCTs) to examine functional outcomes related to cognitive health in community-dwelling older adults. Research monitored changes in some trials, which reported patterns of data related to the rate of change on memory recall tasks for the polyvitamin group compared to the placebo group. Findings were mixed across different trials and different cognitive tests. The results apply only to the populations studied, which were often generally well-nourished, and comparative evidence is lacking across diverse populations.

Research on Broad, Long-term Prevention of Chronic Diseases

Extremely large-scale, long-term RCTs have examined polyvitamin use against hard clinical endpoints, such as the incidence of Total Invasive Cancer and Major Cardiovascular Events. Studies monitored the incidence of these major diseases and all-cause mortality. Studies reported measurements where total invasive cancer incidence and major cardiovascular events were similar across both the polyvitamin and placebo arms. Data showed no consistent patterns related to a change in the overall risk of these major chronic diseases in the study populations.

Key Limitations and What Remains Uncertain about Polyvitamin Evidence

The existing body of evidence highlights several areas where certainty remains low. The evidence quality varies across studies, which often excluded individuals known to be deficient at the start. Data for certain groups remain insufficient, and long-term effects on all biological processes are not fully established. Research is ongoing regarding the durability of observed changes and the specific effects on individuals with confirmed multiple baseline deficiencies.

Key Studies & References

Frequently Asked Questions (FAQ)

Common questions about Гендевит (FAQ)

Q: Does Gendevit help with fatigue and sleepiness?

The B-group vitamins included in Gendevit, such as Thiamine and Riboflavin, are described in official information as coenzymes essential for chemical reactions in the body. These vitamins are known to function in energy metabolism pathways, supporting overall metabolic processes.

Q: Is it true that Gendevit helps improve the condition of skin and hair?

According to official documentation, Vitamin A influences specific signaling patterns related to cell renewal and differentiation. This mechanism is known to impact the structural integrity of the skin and mucous membranes.

Q: Does Gendevit affect the function of the stomach or intestines?

Regulatory documents note that potential adverse reactions often include gastrointestinal upset, such as nausea or abdominal discomfort. Furthermore, the official interaction profile indicates that the preparation can affect the absorption of certain co-administered medicinal products and nutrients.

Q: Which vitamin dosages in Gendevit are considered high?

Safety literature focuses on the risk of exceeding the Tolerable Upper Intake Level (UL) for fat-soluble vitamins, primarily Vitamin A and Vitamin D2. Exceeding this regulatory threshold is associated with the risk of severe toxicity (hypervitaminosis).

Q: What are the general expectations from taking a full course of Gendevit?

The official purpose of the drug is the prophylaxis (prevention) of hypovitaminosis by providing an additional source of essential micronutrients. The official purpose relates to supporting the body's normal physiological and metabolic processes during periods of increased demand or inadequate diet.

Q: If I have a chronic illness, can I take Gendevit?

Official documents list specific chronic conditions that are contraindications (e.g., severe renal insufficiency, diabetes mellitus, sugar metabolism disorders). Other conditions, such as severe hepatic impairment, require special caution. Eligibility depends entirely on the specific disease, as outlined in the regulatory label.

Q: Why does Gendevit contain sugar (or other excipients)?

Auxiliary substances, known as excipients, are added to the formulation to create a stable, protected, and palatable dosage form for oral administration. The presence of sugars and related compounds is specifically noted in the regulatory label because it constitutes a contraindication for patients with known sugar metabolism disorders.

Q: What should I do if I missed a dose of Gendevit?

Regulatory guidance states that if a dose is missed, individuals should take the next scheduled dose at the usual time and avoid taking a double dose to compensate.

Q: Do I need to follow a specific diet while taking Gendevit?

Official administration instructions state that the product should be taken after meals. The regulatory interactions section also notes certain substances, such as chronic alcohol consumption, which are described as potentially impairing vitamin absorption.

Q: Why is Gendevit sold as a dragee/tablet?

The choice of the dragee (coated tablet) pharmaceutical form is defined in regulatory standards. This form is selected to ensure the stability and protection of the active vitamin ingredients, especially fat-soluble ones, and to provide an acceptable taste for oral intake.

Q: Can Gendevit affect blood test results?

Official safety warnings note that the presence of folic acid, a component often included in polyvitamins, can potentially mask the hematological signs of megaloblastic anemia. This effect may influence the interpretation of certain blood tests.

Q: What should be done in case of accidental Gendevit overdose?

Regulatory documentation describes the acute and chronic signs of toxicity, known as hypervitaminosis (especially from Vitamins A and D). Upon suspicion of overdose, official documentation indicates the necessity of consulting a medical professional.

Q: Does Gendevit contain any dyes or preservatives that I should know about?

Official regulatory labeling requires a complete listing of all excipients, which includes any dyes or preservatives used in the formulation. This disclosure is necessary to inform patients who may have known hypersensitivities or specific metabolism disorders.

Q: Is it true that Gendevit can color urine?

The presence of Riboflavin (Vitamin B2) in the composition leads to the formation of metabolites that are known to cause a harmless physiological effect. This is the reason why the urine may appear bright yellow or orange during the course of administration.

How should Гендевит be stored and disposed of?

How to Store and Dispose of Genadewit (Гендевит)

Official regulatory documents define specific conditions for the storage and disposal of Genadewit dragees.

Storage Requirements

Condition	Requirement
Temperature	Store at a temperature not exceeding 25°C
Environmental Protection	Must be stored in a dry place and protected from light
Child Safety	Must be kept out of the reach of children